Provided by Tiger Fintech (Singapore) Pte. Ltd.

Athira Pharma, Inc.

0.2878
+0.01886.99%
Post-market: 0.30000.0122+4.24%19:33 EDT
Volume:199.71K
Turnover:55.50K
Market Cap:11.24M
PE:-0.11
High:0.2973
Open:0.2800
Low:0.2601
Close:0.2690
Loading ...
Apr 16, 2025

Major Issues Report

Form 8-K - Current report
Feb 28, 2025

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Feb 28, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 28, 2025

Major Issues Report

Form 8-K - Current report
Jan 02, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 02, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 02, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 02, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 08, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 07, 2024

Major Issues Report

Form 8-K - Current report
Nov 07, 2024

Beneficial Ownership Change

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Oct 31, 2024

Beneficial Ownership Change

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
Oct 25, 2024

Correspondence

Form CORRESP - Correspondence
Oct 18, 2024

Major Issues Report

Form 8-K - Current report
Oct 08, 2024

Major Issues Report

Form 8-K - Current report
Sep 17, 2024

Major Issues Report

Form 8-K - Current report
Sep 05, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 03, 2024

Major Issues Report

Form 8-K - Current report
Aug 09, 2024

[Rev.]Quaterly Report

Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]